ISPC Stock Price, Chart, Stats & News

iSpecimen Inc. (ISPC) does not currently pay a dividend.
ISPC chart
Fundamentals
Gross margin | 21.55% |
Operating margin | -361.81% |
Pretax margin | -343.99% |
Net margin | -343.99% |
Effective tax rate | – |
ROA | -128.18% |
ROE | -531.83% |
D/E | 0.09x |
Interest coverage ratio | -54.09x |
ISPC valuation
P/E | – |
P/S | 0.24x |
P/B | 0.28x |
P/CF | -0.13x |
P/FCF | -0.12x |
P/OCF | -0.13x |
PEG | -0.01x |
EV multiple | -0.35x |
About
iSpecimen Inc. operates a sophisticated technological platform that effectively bridges the gap between life science researchers and crucial human biological materials. Its proprietary cloud-based system empowers scientists to efficiently locate and access a vast array of biospecimens—such as biofluids, tissues, and living cells—as well as connect with potential study subjects, all sourced from a global network of healthcare providers, including hospitals, laboratories, biobanks, and blood centers. The company develops and manages iSpecimen Marketplace, an innovative online hub that strategically links medical researchers requiring access to subjects, samples, and pertinent data with organizations that hold these invaluable resources. iSpecimen's clientele primarily includes biopharmaceutical firms, in vitro diagnostics companies, and governmental and academic research institutions.
Similar securities
Based on sector and market capitalization











